within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01D_CytotoxicAntibioticsAndRelatedSubstances.L01DB04_Aclarubicin;
model Aclarubicin 
   extends Pharmacolibrary.Drugs.ATC.L.L01DB04;

  annotation(Documentation(
    info ="<html><body><p>Aclarubicin is an anthracycline antibiotic that was previously used as a chemotherapy agent mainly for the treatment of acute leukemia and some solid tumors. Its use has become limited or obsolete in many countries, and it is generally not used as a first-line therapy today due to the availability of better tolerated and more effective alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adult patients based on published sources about aclarubicin after intravenous administration.</p><h4>References</h4><ol><li><p>Fujita, H, et al., &amp; Murata, S (1986). Pharmacokinetics of doxorubicin, (2&quot;R)-4&#x27;-O-tetrahydropyranyl-adriamycin and aclarubicin. <i>The Japanese journal of antibiotics</i> 39(5) 1321–1336. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3463778/&quot;>https://pubmed.ncbi.nlm.nih.gov/3463778</a></p></li><li><p>Geodakian, SV, et al., &amp; Fomina, IP (1987). [Pharmacokinetic study of aclarubicin. The pharmacokinetics of the preparation and its biologically active metabolites in the blood of rats]. <i>Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology</i> 32(10) 768–772. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3480699/&quot;>https://pubmed.ncbi.nlm.nih.gov/3480699</a></p></li><li><p>Lu, W, et al., &amp; Jiang, X (2007). Aclarubicin-loaded cationic albumin-conjugated pegylated nanoparticle for glioma chemotherapy in rats. <i>International journal of cancer</i> 120(2) 420–431. DOI:<a href=&quot;https://doi.org/10.1002/ijc.22296&quot;>10.1002/ijc.22296</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17066446/&quot;>https://pubmed.ncbi.nlm.nih.gov/17066446</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Aclarubicin;
